- CSR Summary Not Yet Available
- NCT00060944
- Primary Citation
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameTrabectedinProduct NameYONDELIS®Therapeutic AreaCancers and Other NeoplasmsEnrollment270% Female63%% White91.1%
Product ClassAntineoplastic AgentsSponsor Protocol NumberET743-STS-201Data PartnerJohnson & JohnsonCondition StudiedLiposarcoma/Leiomyosarcoma, AdvancedMean/Median Age (Years)53
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available